Photochemotherapy of Infrared Active BODIPY-Appended Iron(III) Catecholates for in Vivo Tumor Growth Inhibition

Garai, Aditya and Gandhi, Armin and Ramu, Vanitha and Raza, Md Kausar and Kondaiah, Paturu and Chakravarty, Akhil R (2018) Photochemotherapy of Infrared Active BODIPY-Appended Iron(III) Catecholates for in Vivo Tumor Growth Inhibition. In: ACS OMEGA, 3 (8). pp. 9333-9338.

PDF ACS_Ome_3-8_9333_2018.pdf - Published Version Restricted to Registered users only Download (2MB) | Request a copy

Abstract

Iron(III) catecholates of BODIPY (boron dipyrromethene)-conjugated dipicolylamine ligands, viz. Fe (L-1)(cat)Cl] (1) and Fe(L-2)(cat)Cl] (2) (H(2)cat = catechol), with a ligand-to-metal charge transfer band at similar to 800 nm were studied for their in vivo activity in dark and infrared light in luciferase-expressing human breast adenocarcinoma (BT474luc) cells. Complex 2 displayed in vitro photo cytotoxicity in BT474luc cells (IC50: 6 mu M) in infrared light nm of 600-720 nm with moderate dark toxicity (IC50: 18 mu M) as evidenced from the MTT and Annexin-V FITC/PI staining assays: The mitochondria-localizing complexes showed apoptotic cell death involving reactive oxygen species whose generation was evidenced from 2,7-dichlorofluorescein diacetate assay. In vivo studies showed tumor growth inhibition in mice with an optimized complex 2 dose of 5 mg per kg body weight on exposure to infrared light of 685 nm (dose of 20 mW/cm(2)). The in vivo results exemplify complex 2 as a unique iron based infrared active photochemotherapeutic agent.

Item Type:	Journal Article
Publication:	ACS OMEGA
Publisher:	AMER CHEMICAL SOC
Additional Information:	Copy right for this article belong to AMER CHEMICAL SOC
Department/Centre:	Division of Biological Sciences > Molecular Reproduction, Development & Genetics Division of Chemical Sciences > Inorganic & Physical Chemistry
Date Deposited:	18 Oct 2018 13:09
Last Modified:	18 Oct 2018 13:09
URI:	http://eprints.iisc.ac.in/id/eprint/60909

Actions (login required)

View Item